-
Neuronata-R retains conditional approval in South Korea
- July 19, 2026
- Posted by:
- Category: News
No Comments
South Korea’s Ministry of Food and Drug Safety (MFDS) updates the stem cell therapy’s approval in May 2026 — as the developer works to resume supply and build a U.S. research baseSEOUL, South Korea, July 19, 2026 /PRNewswire/…
-
Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India
- July 19, 2026
- Posted by:
- Category: business
Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide’s fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an equity value of approximately CHF 1.46 billion.Strong transaction support,…
-
VERBAL BEGINNINGS TEAMSTERS TO LAUNCH STRIKE
- July 19, 2026
- Posted by:
- Category: News
Maryland Behavior Technicians Demand a First Contract with Fair WagesROCKVILLE, Md., July 19, 2026 /PRNewswire/ — A group of 33 workers at Verbal Beginnings, represented by Teamsters Local 639, will launch a strike at 6:30 a.m. on Monday,…